Quantum BioPharma Update on Litigation with Dr. Raza Bokhari

Quantum BioPharma Ltd. has announced its upcoming court appearance on January 24, 2025, seeking to have Dr. Raza Bokhari declared a vexatious litigant. Dr. Bokhari, former CEO of FSD Pharma, Inc., was dismissed for cause in July 2021. The Ontario Superior Court case follows previous legal proceedings awarding Quantum BioPharma approximately $3 million related to wrongful dismissal claims by Dr. Bokhari.

Arbitrator Cunningham had previously dismissed Dr. Bokhari's claims, with resulting awards totaling CDN $2.81 million. Quantum BioPharma has initiated collection actions in the United States with additional awards and judgments entered against Dr. Bokhari.

As the legal battle continues, Quantum seeks confirmation of its arbitration victory and awaits further appeals process outcomes in the United States Court of Appeals. The situation underscores ongoing judicial efforts by the biopharmaceutical company to resolve disputes and collect awarded funds.